APA (7th ed.) Citation

Willis, C., Tan, M. S., Bauer, H., Au, T. H., Tantravahi, S. K., Gilreath, J., . . . Stenehjem, D. D. (2021). Treatments and outcomes for patients with myelodysplastic syndrome (MDS) by Revised International Prognostic Scoring System (IPSS-R) scores at the Huntsman Cancer Institute (HCI). Journal of clinical oncology, 39(15_suppl), e19034. https://doi.org/10.1200/JCO.2021.39.15_suppl.e19034

Chicago Style (17th ed.) Citation

Willis, Connor, et al. "Treatments and Outcomes for Patients with Myelodysplastic Syndrome (MDS) by Revised International Prognostic Scoring System (IPSS-R) Scores at the Huntsman Cancer Institute (HCI)." Journal of Clinical Oncology 39, no. 15_suppl (2021): e19034. https://doi.org/10.1200/JCO.2021.39.15_suppl.e19034.

MLA (9th ed.) Citation

Willis, Connor, et al. "Treatments and Outcomes for Patients with Myelodysplastic Syndrome (MDS) by Revised International Prognostic Scoring System (IPSS-R) Scores at the Huntsman Cancer Institute (HCI)." Journal of Clinical Oncology, vol. 39, no. 15_suppl, 2021, p. e19034, https://doi.org/10.1200/JCO.2021.39.15_suppl.e19034.